References
- Budirahardja Y, Gonczy P. Coupling the cell cycle to development. Development 2009; 136:2861 - 2872
- Kastan MB, Bartek J. Cell cycle checkpoints and cancer. Nature 2004; 432:316 - 323
- Lee HO, Davidson JM, Duronio RJ. Endoreplication: Polyploidy with purpose. Genes Dev 2009; 23:2461 - 2477
- Torres EM, Williams BR, Amon A. Aneuploidy: Cells losing their balance. Genetics 2008; 179:737 - 746
- Darzynkiewicz Z. Critical aspects in analysis of cellular DNA content. Curr Protoc Cytom 2010; 7:2 - 7
- Burns ER, Bagwell CB, Hinson WG, Pipkin JL Jr, Hudson JL. Preparation and stability of sixteen murine tissues and organs for flow cytometric cell cycle analysis. Cytometry 1983; 4:150 - 160
- Darzynkiewicz Z, Juan G. DNA content measurement for DNA ploidy and cell cycle analysis. Curr Protoc Cytom 2001; 7:5 - 7
- Foiry L, Megret J, Junien C, Gourdon G. A simple and fast method for cell recovery and DNA content analysis from various mouse tissues by flow cytometry. Cytotechnology 2006; 52:107 - 112
- Thornthwaite JT, Sugarbaker EV, Temple WJ. Preparation of tissues for DNA flow cytometric analysis. Cytometry 1980; 1:229 - 237
- Krishan A, Cabana R. Flow cytometric analysis of electronic nuclear volume and DNA content in normal mouse tissues. Cell Cycle 2004; 3:380 - 383
- Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3:323 - 327
- Speidel D, Helmbold H, Deppert W. Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress. Oncogene 2006; 25:940 - 953
- Wersto RP, Chrest FJ, Leary JF, Morris C, Stetler-Stevenson MA, Gabrielson E. Doublet discrimination in DNA cell cycle analysis. Cytometry 2001; 46:296 - 306
- Suresh R, Aravindan GR, Moudgal NR. Quantitation of spermatogenesis by DNA flow cytometry: comparative study among six species of mammals. J Biosci 1992; 17:413 - 419
- Bocking A, Nguyen VQ. Diagnostic and prognostic use of DNA image cytometry in cervical squamous intraepithelial lesions and invasive carcinoma. Cancer 2004; 102:41 - 54
- Briggs CD, Neal CP, Mann CD, Steward WP, Manson MM, Berry DP. Prognostic molecular markers in cholangiocarcinoma: A systematic review. Eur J Cancer 2009; 45:33 - 47
- Doak SH. Aneuploidy in upper gastro-intestinal tract cancers—a potential prognostic marker?. Mutat Res 2008; 651:93 - 104
- Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1,331 frozen breast cancer specimens. Cancer 1988; 61:420 - 427
- Schulze-Garg C, Lohler J, Gocht A, Deppert W. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland. Oncogene 2000; 19:1028 - 1037
- Heinlein C, Krepulat F, Lohler J, Speidel D, Deppert W, Tolstonog GV. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis. Int J Cancer 2008; 122:1701 - 1709
- Darzynkiewicz Z, Li X, Gong J. Assays of cell viability: Discrimination of cells dying by apoptosis. Methods Cell Biol 1994; 41:15 - 38
- Coates PJ, Lorimore SA, Wright EG. Cell and tissue responses to genotoxic stress. J Pathol 2005; 205:221 - 235
- Heinrichs S, Deppert W. Apoptosis or growth arrest: Modulation of the cellular response to p53 by proliferative signals. Oncogene 2003; 22:555 - 571
- Slatter TL, Ganesan P, Holzhauer C, Mehta R, Rubio C, Williams G, et al. p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors. Cell Death Differ 2010; 17:540 - 550
- Ishikawa K, Ishii H, Saito T. DNA damage-dependent cell cycle checkpoints and genomic stability. DNA Cell Biol 2006; 25:406 - 411